|
ABCE1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.52089999999605E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.07040000000225E-05 |
| Normal-vs-Stage2 |
4.384400E-04 |
| Normal-vs-Stage3 |
6.37849999999274E-05 |
| Normal-vs-Stage4 |
2.10619999999606E-05 |
| Stage1-vs-Stage2 |
5.571000E-01 |
| Stage1-vs-Stage3 |
3.903800E-01 |
| Stage1-vs-Stage4 |
3.151000E-01 |
| Stage2-vs-Stage3 |
9.592400E-01 |
| Stage2-vs-Stage4 |
7.569200E-01 |
| Stage3-vs-Stage4 |
7.583200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.00079999999048E-05 |
| Normal-vs-AfricanAmerican |
7.484500E-03 |
| Normal-vs-Asian |
1.295960E-03 |
| Caucasian-vs-AfricanAmerican |
8.831400E-01 |
| Caucasian-vs-Asian |
7.731200E-01 |
| AfricanAmerican-vs-Asian |
9.503800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.07429999998787E-06 |
| Normal-vs-Female |
5.530499999995E-05 |
| Male-vs-Female |
1.547590E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.590900E-04 |
| Normal-vs-Age(41-60Yrs) |
8.30289999975697E-07 |
| Normal-vs-Age(61-80Yrs) |
4.02330000000006E-05 |
| Normal-vs-Age(81-100Yrs) |
3.348600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.700300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.560000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.960400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.247400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.140800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.892200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.889400E-01 |
| Classical-VS-Follicular |
1.999660E-03 |
| Classical-VS-Other |
1.311610E-01 |
| Classical-VS-Normal |
4.406500E-04 |
| Tall-VS-Follicular |
8.750200E-02 |
| Tall-VS-Other |
1.777230E-01 |
| Tall-VS-Normal |
2.226400E-02 |
| Follicular-VS-Other |
6.810200E-01 |
| Follicular-VS-Normal |
8.91540000047542E-07 |
| Other-VS-Normal |
5.040000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.44799999955015E-07 |
| Normal-vs-N1 |
1.625020E-04 |
| N0-vs-N1 |
6.948000E-01 |
|
|
